Compare OGN & TROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | TROX |
|---|---|---|
| Founded | 1923 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2012 |
| Metric | OGN | TROX |
|---|---|---|
| Price | $13.38 | $7.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 8 |
| Target Price | ★ $11.40 | $6.36 |
| AVG Volume (30 Days) | ★ 5.0M | 3.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 0.60% | ★ 2.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | $2,898,000,000.00 |
| Revenue This Year | $0.45 | $6.94 |
| Revenue Next Year | $1.67 | $5.91 |
| P/E Ratio | $24.28 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.69 | $2.86 |
| 52 Week High | $13.48 | $10.59 |
| Indicator | OGN | TROX |
|---|---|---|
| Relative Strength Index (RSI) | 74.68 | 42.80 |
| Support Level | $10.05 | $6.13 |
| Resistance Level | $13.46 | $8.80 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.22 | -0.06 |
| Stochastic Oscillator | 47.50 | 24.04 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.